[{"Assets_0_Q1_USD":59741000000.0,"CommonStockSharesConverted_0_Q1_shares":1254000000.0,"CommonStockSharesOutstanding_0_Q1_shares":1254000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1436000000.0,"NetIncomeLossConverted_1_Q1_USD":1538000000.0,"RevenuesConverted_1_Q1_USD":5548000000.0,"StockholdersEquity_0_Q1_USD":22067000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1270000000.0,"StockholdersEquityConverted_0_Q1_USD":22179000000.0,"EarningsPerShareBasic_1_Q1_USD":1.23,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1262000000.0,"EarningsPerShareDiluted_1_Q1_USD":1.22,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.68,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200506"}]